33 results
8-K
KANT
Kineta, Inc.
13 Sep 24
Entry into a Material Definitive Agreement
5:20pm
not to file any lawsuit or other legal action against the Company related to the Outstanding Debt, or to otherwise cause the Confession to be entered into any
8-K
EX-10.1
KANT
Kineta, Inc.
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
by law and/or otherwise permitted by this Agreement.
By signing this Agreement, you waive any right to bring a lawsuit against the Released Parties
8-K
EX-10.2
KANT
Kineta, Inc.
29 Feb 24
Kineta Announces Restructuring and Exploration of Strategic Alternatives
7:00am
permitted by this Agreement.
By signing this Agreement, you waive any right to bring a lawsuit against the Released Parties and any right
8-K
EX-10.1
dsl9u9wb1x
16 Aug 21
Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants
7:21am
8-K/A
EX-99.3
47sblpqfuz xzgg
3 Feb 21
Other Events
4:59pm
8-K
EX-10.1
x9yflnyc
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
8-K
98ttpibxmfk
9 Dec 20
Other Events
5:27pm
425
l3ki0 ujy5h
9 Dec 20
Business combination disclosure
5:25pm
8-K
EX-99.1
65iwg5hlcg85j
4 Dec 20
Other Events
5:17pm
425
EX-99.1
g8tz1rvlam783yt 3fg
4 Dec 20
Business combination disclosure
5:16pm
424B3
ad0bfe
12 Nov 20
Prospectus supplement
6:08am
S-4/A
EX-10.23
g8hehkxt8ff
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm